New AI Model Speeds Up Brain Tumor Detection in Surgery for Improved Patient Outcomes
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Microscopy |
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Breast |
Alverno Laboratories has expanded its use of Ibex’s AI-powered cancer diagnostics platform to include breast cancer detection for patients.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Molecular Diagnostics, Prostate |
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Cancer |
The NCCN updated its Clinical Practice Guidelines to broaden genetic testing recommendations for high-risk cancer types.
Read MorePosted by Chris Wolski | Nov 1, 2024 | Cancer |
The University of Florida Health Cancer Center has introduced a 40-foot mobile cancer screening bus to provide essential cancer screenings.
Read More